You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 11, 2025

Drug Price Trends for SPINOSAD


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for SPINOSAD

Best Wholesale Price for SPINOSAD

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
SPINOSAD 0.9% SUSP,TOP Allegis Holdings, LLC 28595-0570-04 120ML 151.39 1.26158 ML 2023-08-15 - 2028-08-14 FSS
SPINOSAD 0.9% SUSP,TOP Allegis Holdings, LLC 28595-0570-04 120ML 156.77 1.30642 ML 2024-01-01 - 2028-08-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Global Spinosad Market Analysis and Price Projections

Market Overview

Spinosad, a naturally derived insecticide and pharmaceutical agent, is gaining significant traction globally due to its efficacy, environmental friendliness, and broad-spectrum insecticidal activity. Here’s a comprehensive analysis of the market and price projections for spinosad.

Market Size and Growth

The global spinosad market is projected to experience substantial growth over the next few years. As of 2024, the market size is estimated to be around USD 751.2 million and is expected to expand at a compound annual growth rate (CAGR) of 8.00% from 2024 to 2031[1].

Another report indicates that the market will grow from USD 182 million in 2024 to USD 303.7 million by 2030, at a CAGR of 8.9% during the forecast period[2].

Regional Market Dynamics

North America

North America dominates the spinosad market, accounting for around 40% of the global revenue in 2024. This dominance is driven by increasing demand for organic products and concerns over the adverse effects of chemical pesticides on human health and the environment. The region's CAGR is expected to be around 6.2% from 2024 to 2031[1].

Asia Pacific

The Asia Pacific region is the fastest-growing market for spinosad, with a market size of USD 172.78 million in 2024 and a projected CAGR of 10.0% from 2024 to 2031. This growth is fueled by the expanding agriculture industry, growing demand for organic products, and the adoption of integrated pest management practices[1].

Europe and Other Regions

Europe also holds a significant share, with a market size of USD 225.36 million in 2024 and a CAGR of 6.5% from 2024 to 2031. Latin America and the Middle East & Africa regions, though smaller, are expected to grow at CAGRs of 7.4% and 7.7%, respectively, during the same period[1].

Applications and End-Users

Agricultural Sector

Spinosad is widely used in agriculture to control pests on over 200 different crops, including cotton, cabbage, apples, and citrus. Its application in this sector is driven by the need for sustainable pest control methods and the increasing resistance of pests to synthetic pesticides[4].

Veterinary Medicine

In veterinary medicine, spinosad is used to control fleas and ticks on pets. Elanco Animal Health has developed spinosad for significant animal health uses, including direct application to animals and application to animal production premises[4].

Public Health

Spinosad also finds application in public health, particularly in controlling household pests. Its use in this sector is growing due to its low toxicity to non-target organisms and its effectiveness against a broad spectrum of pests[3].

Market Drivers

  • Increasing Demand for Organic Products: The global shift towards organic farming and the growing demand for eco-friendly products are significant drivers for the spinosad market[3].
  • Integrated Pest Management (IPM): The adoption of IPM techniques, which emphasize the use of natural and biological pest control methods, further fuels the demand for spinosad[3].
  • Regulatory Approvals: Stricter environmental regulations favoring safer alternatives to synthetic pesticides also contribute to the market's growth[3].

Market Restraints

  • Intellectual Property Rights: Issues related to intellectual property rights can curtail innovation within the spinosad sector[3].
  • Competitive Alternatives: The presence of competitive alternatives in pest control can limit the growth opportunities for spinosad products[3].
  • Regulatory Challenges: Stringent regulatory frameworks affecting the production and distribution of spinosad can also pose challenges[3].

Market Opportunities

  • Pet Care Industry: The potential for spinosad in the pet care industry to combat flea and tick infestations is a significant opportunity[3].
  • Organic Farming: The growing demand for spinosad in organic farming as a natural pesticide alternative presents another key opportunity[3].
  • Household Pest Control: The use of spinosad-based solutions in the household pest control market is also an emerging opportunity[3].

Competitive Landscape

The global spinosad market is highly competitive, with key players including:

  • Dow AgroSciences: Holding a significant market share, Dow AgroSciences is a major player in the agricultural chemicals sector[4].
  • Elanco: Specializing in animal health, Elanco has developed spinosad for various veterinary applications[4].
  • Qilu Pharmaceutical: Along with Baicao Biotech Co., Ltd, and Corteva Agriscience, these companies are prominent in the production and distribution of spinosad[2].

Price Projections

The market size and growth projections indicate a steady increase in demand, which is likely to influence pricing. Here are some key points:

  • Current Market Size: USD 751.2 million in 2024[1].
  • Forecasted Market Size: USD 303.7 million by 2030 for the active ingredient market[2], and USD 1088.42 million by 2028 for the broader spinosad market[4].
  • CAGR: Ranging from 7.52% to 8.9% depending on the segment and forecast period[2][4].

Given the increasing demand and limited supply in some regions, prices are likely to remain stable or increase slightly over the forecast period. However, fluctuations in raw material prices and competitive pressures could influence pricing dynamics.

Key Takeaways

  • The global spinosad market is expected to grow significantly, driven by demand for organic and eco-friendly pest control solutions.
  • North America and Asia Pacific are key regions driving market growth.
  • The agricultural sector remains the largest application area, followed by veterinary medicine and public health.
  • Market growth is supported by regulatory approvals, IPM practices, and increasing awareness of environmental preservation.
  • Despite opportunities, the market faces challenges such as intellectual property issues and competitive alternatives.

FAQs

Q: What is the current market size of the global spinosad market? A: The global spinosad market size is estimated to be around USD 751.2 million in 2024[1].

Q: What is the projected CAGR for the global spinosad market from 2024 to 2031? A: The market is expected to expand at a CAGR of 8.00% from 2024 to 2031[1].

Q: Which region is the fastest-growing market for spinosad? A: The Asia Pacific region is the fastest-growing market for spinosad, with a projected CAGR of 10.0% from 2024 to 2031[1].

Q: What are the main applications of spinosad? A: Spinosad is primarily used in agriculture, veterinary medicine, and public health to control pests[3][4].

Q: Who are the key players in the global spinosad market? A: Key players include Dow AgroSciences, Elanco, Qilu Pharmaceutical, and Baicao Biotech Co., Ltd[2][4].

Sources

  1. Cognitive Market Research: Spinosad Market Report 2024.
  2. Valuates Reports: Global Spinosad Active Ingredient Market Insights, Forecast to 2030.
  3. 360iResearch: Technical Spinosad Market Size & Share 2025-2030.
  4. Maia Research: Global Spinosad Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.